Correction: Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore

Clarence Ong (), Jamaica Briones, Zhi Zhen Lim, Nisha Suyien Chandran, Haur Yueh Lee, Benny Kaihui Li, Yik Weng Yew and Hwee-Lin Wee
Additional contact information
Clarence Ong: National University of Singapore and National University Health System
Jamaica Briones: National University of Singapore and National University Health System
Zhi Zhen Lim: National University of Singapore and National University Health System
Nisha Suyien Chandran: National University Hospital
Haur Yueh Lee: Singapore General Hospital
Benny Kaihui Li: National Skin Centre
Yik Weng Yew: National Skin Centre
Hwee-Lin Wee: National University of Singapore and National University Health System

PharmacoEconomics - Open, 2024, vol. 8, issue 6, No 15, 961 pages

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-024-00516-4 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:8:y:2024:i:6:d:10.1007_s41669-024-00516-4

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-024-00516-4

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().